Learn About Chordoma

View Main Condition: Brain Tumor

What is the definition of Chordoma?

A chordoma is a rare type of cancerous tumor that can occur anywhere along the spine, from the base of the skull to the tailbone. Chordomas grow slowly, gradually extending into the bone and soft tissue around them. They often recur after treatment, and in about 40 percent of cases the cancer spreads (metastasizes) to other areas of the body, such as the lungs.

What are the causes of Chordoma?

Changes in the TBXT gene have been associated with chordoma. An inherited duplication of the TBXT gene identified in a few families is associated with an increased risk of developing a chordoma. Duplications or increases in activity (expression) of the TBXT gene have also been identified in people with chordoma who have no history of the disorder in their family. In these individuals, the changes occur only in the tumor cells and are not inherited.

How prevalent is Chordoma?

Chordomas are rare, occurring in approximately 1 per million individuals each year. Chordomas comprise fewer than 1 percent of tumors affecting the brain and spinal cord.

Is Chordoma an inherited disorder?

When development of a chordoma is associated with a duplication of the TBXT gene inherited from a parent, one copy of the altered gene in each cell is sufficient to increase the risk of the disorder, which is an inheritance pattern called autosomal dominant. People with this duplication inherit an increased risk of this condition, not the condition itself.

Who are the top Chordoma Local Doctors?
Elite in Chordoma
Neurosurgery | Surgical Oncology
Elite in Chordoma
Neurosurgery | Surgical Oncology

MD Anderson

2130 W Holcombe Blvd, Univ Of Tx M D Ande Life, 
Houston, TX 
Languages Spoken:
English

Laurence Rhines is a Neurosurgery specialist and a Surgical Oncologist in Houston, Texas. Dr. Rhines is rated as an Elite provider by MediFind in the treatment of Chordoma. His top areas of expertise are Chordoma, Bone Tumor, Spinal Tumor, Osteotomy, and Vertebroplasty.

Elite in Chordoma
Elite in Chordoma

Lifespan Physician Group Inc

593 Eddy St Apc, Suite 6, 
Providence, RI 
Languages Spoken:
English
Offers Telehealth

Ziya Gokaslan is a Neurosurgery provider in Providence, Rhode Island. Dr. Gokaslan is rated as an Elite provider by MediFind in the treatment of Chordoma. His top areas of expertise are Chordoma, Tethered Cord Syndrome, Bone Tumor, Laminectomy, and Spinal Fusion.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Chordoma
Elite in Chordoma

Memorial Solid Tumor Group

1275 York Ave, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Mrinal Gounder is an Oncologist in New York, New York. Dr. Gounder is rated as an Elite provider by MediFind in the treatment of Chordoma. His top areas of expertise are Adult Soft Tissue Sarcoma, Desmoid Tumor, Epithelioid Sarcoma, Liposarcoma, and Liver Embolization.

What are the latest Chordoma Clinical Trials?
Allogeneic Stem Cell Transplantation Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion With Zoledronic Acid in Combination to Treat Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory Solid Tumors

Summary: Hematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to decrease GVHD and PTLD and has demonstrated effectiveness for hematologic malignancies and non-malignant diseases additionally increasing the donor pool as to allow for haploidentical transplant to safely occur. While solid tumors can be h...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1b/2 Study of ERAS-601 SHP2 Inhibitor as a Monotherapy in Patients With Advanced and Progressing Chordoma

Summary: The researchers are doing this study is to find out whether ERAS-601 is a safe and effective treatment that causes few or mild side effects in people with advanced and progressing chordoma.

Who are the sources who wrote this article ?

Published Date: May 01, 2015
Published By: National Institutes of Health